Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive impairment.

Seema Joshi1, John E Morley

  • 1Division of Geriatric Medicine, Saint Louis University School of Medicine, 1402 South Grand Boulevard, M238, MO 63104, USA.

The Medical Clinics of North America
|September 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice.

PloS one·2025
Same author

Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR).

The journal of nutrition, health & aging·2025
Same author

Gut microbiota disturbances in hospitalized older adults with malnutrition and clinical outcomes.

Nutrition (Burbank, Los Angeles County, Calif.)·2024
Same author

Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation.

The Journal of biological chemistry·2023
Same author

Low circulating adropin levels in late-middle aged African Americans with poor cognitive performance.

npj aging·2023
Same author

Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps.

Journal of cachexia, sarcopenia and muscle·2023

As global populations age, Alzheimer's disease (AD) prevalence rises, necessitating new treatments. Early intervention in mild cognitive impairment (MCI) may prove crucial for managing dementia effectively.

Area of Science:

  • Neurology
  • Gerontology
  • Public Health

Background:

  • Aging populations are experiencing a rise in dementia prevalence.
  • Alzheimer's disease (AD) is the leading cause of dementia.
  • Current dementia therapies have limitations, and their cost-effectiveness is debated.

Purpose of the Study:

  • To review the current landscape of dementia diagnosis and management.
  • To highlight the growing interest in prodromal states like mild cognitive impairment (MCI).
  • To emphasize the urgent need for disease-modifying treatments for AD.

Main Methods:

  • Review of existing literature and evidence-based practice parameters.
  • Analysis of trends in dementia research and therapeutic development.
  • Exploration of the concept and significance of MCI.

Related Experiment Videos

Main Results:

  • Dementia, particularly AD, poses significant challenges due to increasing prevalence.
  • Effective therapies for dementia are lacking, and existing treatments like cholinesterase inhibitors (ChEIs) face cost-effectiveness questions.
  • There is a surge in AD-related information and a growing focus on early disease stages, including MCI.

Conclusions:

  • Early intervention strategies for dementia, potentially initiated during MCI, are being explored.
  • Disease-modifying treatments for AD are critically needed to address the substantial individual and societal burdens.
  • Promising research avenues exist for developing novel, disease-altering therapies for Alzheimer's disease.